Welcome to the website of Michael Schlander,
- Professor of Health Economics at the University of Heidelberg
and - Head of Division of Health Economics at German Cancer Research Center (DKFZ)
- Founder and Chairman of InnoValHC,
Institute for Innovation & Valuation in Health Care
[founding member, Alliance for the Advancement of Applied Health Economics, A3HE]
News
2024
Article on "Anxiety and depression in cancer patients and survivors in the context of restrictions in contact and oncological care during the COVID-19 pandemic"
Recently published research article in the renowned International Journal of Cancer (online available as of October 2024) -- Clinical and sociodemographic risk factors for anxiety and depression were analyzed for cancer patients and survivors during the COVID-19 pandemic. In particular, study findings highlight the importance of social contact as a modifiable risk factor for the mental health of cancer patients.
Heidelberg Health Economics Summer School 2024
The Heidelberg Health Economics Summer School 2024, a high-level, full week program offered by the the Institute for Innovation & Valuation in Health Care (InnoValHC) under the auspices of the Ruprecht-Karls-University Heidelberg, addressed the role of (health) economic evaluation in the regulatory context of formal Health Technology Assessments (HTAs).
The Summer School took place at NOBIS / NOI Techpark in Bruneck-Brunico / Italy from September 23-27, 2024 - for more detailed information, please visit the InnoValHC website.
The socio-economic consequences of cancer - An underestimated problem
Organisation of European Cancer Institutes (OECI) task force consensus recommendations on conceptual framework, taxonomy, and research directions - "The socioeconomic impact of cancer on patients and their relatives" - recently published in Lancet Oncology (online available as of April 2024).
